Tobias Obejum Apinjoh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 18 | 2022 | 953 | 3.920 |
Why?
|
| Plasmodium falciparum | 14 | 2023 | 1634 | 2.260 |
Why?
|
| Malaria | 13 | 2023 | 1087 | 2.160 |
Why?
|
| Cameroon | 19 | 2023 | 63 | 1.830 |
Why?
|
| Insecticides | 2 | 2022 | 201 | 1.640 |
Why?
|
| Parasitemia | 9 | 2022 | 173 | 1.610 |
Why?
|
| Antimalarials | 9 | 2022 | 868 | 1.530 |
Why?
|
| Protozoan Proteins | 4 | 2022 | 798 | 1.250 |
Why?
|
| Drug Resistance | 6 | 2022 | 1610 | 1.150 |
Why?
|
| Insecticide-Treated Bednets | 4 | 2019 | 53 | 1.030 |
Why?
|
| Antigens, Protozoan | 2 | 2021 | 314 | 0.880 |
Why?
|
| Anopheles | 2 | 2022 | 205 | 0.810 |
Why?
|
| Urine | 1 | 2021 | 381 | 0.730 |
Why?
|
| Pregnancy Complications, Parasitic | 4 | 2020 | 55 | 0.650 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2015 | 30 | 0.560 |
Why?
|
| Suburban Population | 1 | 2015 | 48 | 0.550 |
Why?
|
| Artemisinins | 4 | 2019 | 214 | 0.440 |
Why?
|
| Sulfadoxine | 2 | 2022 | 47 | 0.420 |
Why?
|
| Pyrimethamine | 2 | 2022 | 95 | 0.410 |
Why?
|
| Plasmodium malariae | 2 | 2022 | 12 | 0.400 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 587 | 0.380 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1203 | 0.340 |
Why?
|
| Genetic Variation | 5 | 2021 | 6664 | 0.330 |
Why?
|
| Rural Population | 2 | 2015 | 2174 | 0.320 |
Why?
|
| Drug Combinations | 3 | 2022 | 1928 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1974 | 0.290 |
Why?
|
| Africa South of the Sahara | 5 | 2022 | 708 | 0.280 |
Why?
|
| Anemia | 3 | 2017 | 1419 | 0.240 |
Why?
|
| Dihydropteroate Synthase | 1 | 2023 | 27 | 0.240 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 23438 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2022 | 15603 | 0.230 |
Why?
|
| Gene Frequency | 5 | 2021 | 3722 | 0.230 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 4352 | 0.230 |
Why?
|
| Helminthiasis | 2 | 2016 | 64 | 0.220 |
Why?
|
| Antigenic Variation | 1 | 2021 | 127 | 0.210 |
Why?
|
| Malaria Vaccines | 1 | 2021 | 140 | 0.190 |
Why?
|
| Erythrocytes | 3 | 2017 | 2410 | 0.180 |
Why?
|
| Child, Preschool | 9 | 2021 | 41198 | 0.180 |
Why?
|
| Infant | 7 | 2021 | 34569 | 0.180 |
Why?
|
| Young Adult | 12 | 2023 | 56226 | 0.180 |
Why?
|
| Cytokines | 1 | 2013 | 7190 | 0.170 |
Why?
|
| Microscopy | 2 | 2021 | 863 | 0.160 |
Why?
|
| Seasons | 2 | 2022 | 1437 | 0.160 |
Why?
|
| Pregnant Women | 1 | 2022 | 504 | 0.160 |
Why?
|
| Plasmodium ovale | 1 | 2017 | 13 | 0.160 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2017 | 85 | 0.150 |
Why?
|
| Alleles | 4 | 2017 | 7099 | 0.150 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 622 | 0.140 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2017 | 183 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1199 | 0.140 |
Why?
|
| Malaria, Cerebral | 1 | 2017 | 127 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 17409 | 0.140 |
Why?
|
| Child | 10 | 2021 | 74468 | 0.140 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 289 | 0.130 |
Why?
|
| Adolescent | 10 | 2021 | 85155 | 0.130 |
Why?
|
| DNA, Protozoan | 1 | 2015 | 230 | 0.130 |
Why?
|
| Family Characteristics | 1 | 2019 | 937 | 0.130 |
Why?
|
| Mosquito Control | 1 | 2015 | 96 | 0.130 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 789 | 0.130 |
Why?
|
| Birth Weight | 1 | 2022 | 1941 | 0.130 |
Why?
|
| Geography | 1 | 2015 | 691 | 0.110 |
Why?
|
| Pregnancy | 8 | 2023 | 27398 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 2719 | 0.110 |
Why?
|
| Humans | 30 | 2023 | 715777 | 0.110 |
Why?
|
| Perinatal Care | 1 | 2014 | 232 | 0.110 |
Why?
|
| Female | 19 | 2023 | 377204 | 0.100 |
Why?
|
| Adult | 13 | 2023 | 212266 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2022 | 3158 | 0.090 |
Why?
|
| Genotype | 2 | 2015 | 12919 | 0.090 |
Why?
|
| Genome, Human | 3 | 2021 | 4471 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2014 | 2034 | 0.090 |
Why?
|
| Genome | 1 | 2017 | 1754 | 0.090 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2008 | 69 | 0.080 |
Why?
|
| Haplotypes | 3 | 2021 | 2885 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1938 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21797 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2021 | 6105 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2017 | 5467 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 13643 | 0.070 |
Why?
|
| Male | 10 | 2021 | 350324 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14902 | 0.070 |
Why?
|
| Middle Aged | 5 | 2021 | 214639 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6274 | 0.070 |
Why?
|
| Selection, Genetic | 2 | 2021 | 886 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2022 | 24798 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58323 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2015 | 9984 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 799 | 0.050 |
Why?
|
| Aged | 3 | 2021 | 162448 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 2937 | 0.050 |
Why?
|
| Africa | 1 | 2021 | 662 | 0.050 |
Why?
|
| Malawi | 1 | 2019 | 238 | 0.040 |
Why?
|
| Prevalence | 4 | 2020 | 14911 | 0.040 |
Why?
|
| Ghana | 1 | 2019 | 277 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16311 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 966 | 0.040 |
Why?
|
| Ethiopia | 1 | 2019 | 462 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 169420 | 0.040 |
Why?
|
| Pan troglodytes | 1 | 2017 | 233 | 0.040 |
Why?
|
| Helminths | 1 | 2016 | 27 | 0.040 |
Why?
|
| Gene Flow | 1 | 2016 | 85 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2017 | 206 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2021 | 991 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 2014 | 119 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2021 | 1545 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2649 | 0.030 |
Why?
|
| Ownership | 1 | 2017 | 325 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7757 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 1220 | 0.030 |
Why?
|
| Topography, Medical | 1 | 2012 | 37 | 0.030 |
Why?
|
| Colorimetry | 1 | 2012 | 135 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 70866 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 461 | 0.020 |
Why?
|
| Blood | 1 | 2012 | 617 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2615 | 0.020 |
Why?
|
| Phylogeny | 1 | 2017 | 2792 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 51315 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1894 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2015 | 1040 | 0.020 |
Why?
|
| Parasite Egg Count | 1 | 2007 | 29 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2008 | 160 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2918 | 0.020 |
Why?
|
| Gravitation | 1 | 2007 | 78 | 0.020 |
Why?
|
| Altitude | 1 | 2008 | 142 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 1502 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 29291 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2768 | 0.020 |
Why?
|
| Rural Health Services | 1 | 2008 | 381 | 0.020 |
Why?
|
| Maternal Age | 1 | 2007 | 791 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1150 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 1496 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 1014 | 0.010 |
Why?
|
| Genomics | 1 | 2017 | 5342 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3947 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6501 | 0.010 |
Why?
|
| Gestational Age | 1 | 2007 | 3446 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3250 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6259 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23464 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15909 | 0.010 |
Why?
|